Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

NCT02831959 is registered in ClinicalTrials.gov with NovoCure GmbH as lead sponsor.

NCT NCT02831959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02831959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Lead sponsor
NovoCure GmbH
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2016
Completion date
November 29, 2024
Enrollment
298 (actual)
Sites
128

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases from non-small cell lung cancer (nsclc)